Pathogenesis, prevention, and therapeutic advances in hepatitis B, C, and D
Abstract Viral hepatitis poses a considerable risk to public health. Among the five hepatitis viruses, hepatitis B, C, and D virus are of particular concern due to their high rates of chronic infection and significant global disease burden. The World Health Organization’s Global Health Sector Strate...
Saved in:
| Main Authors: | Junjie Liu, Tong Yuan, Lin Xue, Huifang Liang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-08-01
|
| Series: | Virology Journal |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12985-025-02907-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Review: Advances in the Pathogenesis and Treatment of Immune Thrombocytopenia Associated with Viral Hepatitis
by: Yanmei Xu, et al.
Published: (2023-09-01) -
Bridging viral hepatitis and liver cancer: Emerging concepts in pathogenesis and therapeutic innovation
by: Keyin Zheng, et al.
Published: (2025-06-01) -
Rethinking therapeutic decisions for hepatitis B infection in Syria: insights into molecular monitoring
by: Wafa Habbal, et al.
Published: (2012-10-01) -
Epidemiology of hepatitis B and C among risk groups in Czechia
by: Iva Bendlova, et al.
Published: (2025-05-01) -
Silicosis: from pathogenesis to therapeutics
by: Bijun Yang, et al.
Published: (2025-01-01)